Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
about
Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applicationsRecent developments in human immunodeficiency virus-1 latency researchConformational flexibility of the oncogenic protein LMO2 primes the formation of the multi-protein transcription complexAnti-CHMP5 single chain variable fragment antibody retrovirus infection induces programmed cell death of AML leukemic cells in vitroSingle domain intracellular antibodies from diverse libraries: emphasizing dual functions of LMO2 protein interactions using a single VH domainRetinoblastoma-independent antiproliferative activity of novel intracellular antibodies against the E7 oncoprotein in HPV 16-positive cellsBifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragments.Engineered antibody variable and constant domains as therapeutic candidates.Isolation, identification and expression of specific human CD133 antibodies.Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluidsA novel intracellular antibody against the E6 oncoprotein impairs growth of human papillomavirus 16-positive tumor cells in mouse models.Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteinsDevelopment of an effective therapy for chronic myelogenous leukemiaImmunoglobulin domains in Escherichia coli and other enterobacteria: from pathogenesis to applications in antibody technologies.A novel anti-alpha-fetoprotein single-chain variable fragment displays anti-tumor effects in HepG2 cells as a single agent or in combination with paclitaxel.Nanoparticles for the delivery of therapeutic antibodies: Dogma or promising strategy?Therapeutic Antibodies against Intracellular Tumor AntigensIn vivo antitumor effect of an intracellular single-chain antibody fragment against the E7 oncoprotein of human papillomavirus 16.New insights and clinical advancements in cellular oncology.
P2860
Q26738678-267EA3F1-13DC-422F-A129-A235D74D88D0Q27013114-5018267D-6BD9-433B-A79B-6AC88ED0C15DQ27681258-28DB77A0-B9C2-4EAE-8183-D4DC257AF198Q33567527-CABDAB14-3C32-4E2F-9717-BA395AB461C9Q33729971-CD320D47-C88A-4641-9E41-0926BA39FB7BQ33795204-18C4FB53-9BBC-440B-893B-6A5A3F7A9CCEQ34117333-CE7F50CD-628B-4ECC-9124-1FA2546BFC1EQ35044156-75BB3147-6857-4839-ABE5-009165F3089EQ35052038-B0BDB7D7-0952-44D9-9C82-ABADBA33BDF0Q36889137-CBE11A24-5465-45D9-B75E-D96987985915Q37085816-DE745B38-C595-4443-BAFA-E097602D4D87Q37961564-8DD85C44-8B51-4E40-8194-24A29FCB9B7DQ37966917-C60E4AAB-D9CC-4280-85CC-894333FEB065Q38020872-F7AAD4AE-B81A-4627-B479-F381E608719AQ38798897-F91F7BF7-6222-447B-ADF9-8C3F2EC82B21Q39049314-A6BC39C6-F04A-43BE-BAEE-46D66A30CA85Q41462883-3DD4B1EC-EAFA-4EA2-80B0-FC9F7DE3DC6BQ42240819-1F2AD027-9C0E-4EFC-992B-EB3ADE04FC9BQ53128619-42A48F98-1C59-4B60-B77E-C9041DB1BA59
P2860
Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
@en
Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
@en-gb
Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
@nl
type
label
Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
@en
Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
@en-gb
Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
@nl
prefLabel
Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
@en
Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
@en-gb
Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
@nl
P2860
P356
P1433
P1476
Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
@en
P2093
David Pérez-Martínez
Tomoyuki Tanaka
P2860
P304
P356
10.1002/BIES.201000009
P407
P577
2010-07-01T00:00:00Z